NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Old Version 1

changes.mady.by.user Kuffel, Gina (NIH/NCI) [C]

Saved on

compared with

New Version 2

changes.mady.by.user Kuffel, Gina (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
  •  
    Anchor
    maincontent
    maincontent

Date

02 Feb

Attendees

Committee MemberPresentAbsent
Kuffel, Gina (NIH/NCI) [C]
X
Amy LeblancX

Otridge, John (NIH/NCI) [C]

X



Kim, Erika (NIH/NCI) [E]
X


Sommers, Connie (NIH/NCI) [E]

X



Debbie KnappX

Toby HechtX

Ralph ParchmentX

Goals

  • Discuss updates to ICDC and define emerging strategies and priorities

SharePoint Site

https://nih.sharepoint.com/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups

Outstanding Action Items


  •  Revisit new steering committee members in September (loop Connie into this discussion) 
  •  Toby to invite Greg from CCDI to the next Executive Team Meeting in January
  •  Toby to look across the NCI directory to find person that has a combination of canine and pediatric oncology background

Agenda

ItemWhoTalking Points
New Steering Committee Members



Post Discussion about FidoCure

All

  • Not clear if we really can have a successful collaboration, however we have let them know if they can find a way to work with us that the ICDC would be interested.
  • Their public data is a candidate for the ICDC
  • They are interested in correlating data with biomarkers and that is an area of interest for the ICDC
  • Work instead with peer reviewed and published scientists that use FidoCure data
  • Their data may not be useful to predict outcomes

New ICDC Working Group: Longitudinal Data Acquisition and Use Working Group (LDAUWG)

Purpose: Formulate scientific questions and use cases that can be used to interrogate longitudinal datasets that would justify the ingestion of such data into the ICDC.

All

  • New ICDC  1-pager
  • First meeting is scheduled for Friday March 1st
DGAB Updates

Kuffel, Gina (NIH/NCI) [C] 

ICDC Studies in Active Submission

  • COTC021
    • "Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs in the Adjuvant Setting with Osteosarcoma"
    • Dr. Amy LeBlanc
    • Status: Files have been transferred, but they are not in the requested format
  • UBC03
    • "Transcriptomic analyses of early stage bladder cancer in Scottish Terriers detected through screening"
    • Dr. Debbie Knapp
    • Status: Metadata transfer is in progress
  • OSA02
    • "Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma"
    • Dr. Dawn Duval
    • Status: Files and metadata have been received and are in review
ICDC Biospecimen Data

Kuffel, Gina (NIH/NCI) [C] 

Upcoming Steering Committee Meeting

Ralph Parchment

  • February meeting: Tuesday February 20th
  • The minutes can be reviewed in the meeting invite

Minutes (Not Verbatim)





Previous ICDC Use Cases from Steering Committee

1. Genomic correlates across platforms (DNA, RNA, protein).

...